Calnexin family members as modulators of genetic diseases

Seminars in Cell and Developmental Biology

Volumn 10, Issue 5, 1999, Pages 473-480

  Chevet, E ^a   Jakob, C A ^a,b   Thomas, D Y ^a,b   Bergeron, J J M ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

CFTR; Endoplastic reticulum; Quality control; 1 antitrypsin

Indexed keywords

ALPHA 1 ANTITRYPSIN; CALCIUM BINDING PROTEIN; CALNEXIN; CFTR PROTEIN, HUMAN; PHOSPHOPROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

AMINO ACID SEQUENCE; CYSTIC FIBROSIS; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MULTIGENE FAMILY; REVIEW; SEQUENCE HOMOLOGY;

ALPHA 1-ANTITRYPSIN; AMINO ACID SEQUENCE; CALCIUM-BINDING PROTEINS; CALNEXIN; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; PHOSPHOPROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0033210209     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1006/scdb.1999.0316     Document Type: Article

References (60)

1. Reaves BJ, O'Rahilly S, Whitehead JP. Truncated human leptin (delta133) associated with extreme obesity undergoes proteasomal degradation after defective intracellular transport. Endocrinology. 140:1999;1718-1723.
2. Teckman JH, Omura S, Perlmutter DH. Degradation of a mutant secretory protein, alpha 1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity. J Biol Chem. 271:1996;22791-22795.
3. Kelly EJ, Gitlin JD. Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation. Proc Natl Acad Sci USA. 95:1998;10854-10859.
4. Helenius J, Braakinan I, Helenius A. Cotranslational folding and calnexin binding during glycoprotein synthesis. Proc Natl Acad Sci USA. 92:1995;6229-6233.
5. Helenius A. Lectins as chaperones in glycoprotein folding. Curr Opin Struct Biol. 8:1998;587-592.
6. Prehn S, Hartmann E, Kalies KU, Rapoport TA. A mammalian homolog of SEC61p and SECYp is associated with ribosomes and nascent polypeptides during translocation. Cell. 71:1992;489-503.
7. Voigt S, Rapoport TA, Lingappa VR. TRAM regulates the exposure of nascent secretory proteins to the cytosol during translocation into the endoplasmic reticulum. Cell. 92:1998;621-631.
8. van Riel MC, Martens GJ. Translocon-associated protein TRAP delta and a novel TRAP-like protein are coordinately expressed with pro opiomelanocortin in Xenopus intermediate pituitary. Biochem J. 312:1995;205-213.
9. Tajima S, Lauffer L, Walter P. The beta subunit of the signal recognition particle receptor is a trans- membrane GTPase that anchors the alpha subunit, a peripheral membrane GTPase, to the endoplasmic reticulum membrane. J Cell Biol. 128:1995;273-282.
10. Corsi AK, Schekman R. The lumenal domain of Sec63p stimulates the ATPase activity of BiP and mediates BiP recruitment to the translocon inSaccharomyces cerevisiae. J Cell Biol. 137:1997;1483-1493.
11. Knop M, Finger A, Braun T, Hellmuth K, Wolf DH. Der1, a novel protein specifically required for endoplasmic reticulum degradation in yeast. EMBO J. 15:1996;753.
12. Bordallo J, Plemper RK, Finger A, Wolf DH. Der3p/Hrd1p is required for endoplasmic reticulum-associated degradation of misfolded lumenal and integral membrane proteins. Mol Biol Cell. 9:1998;209-222.
13. Sommer T, Wolf DH. Endoplasmic reticulum degradation: reverse protein flow of no return. FASEB J. 11:1997;1227-1233.
14. Sambrook JF. The involvement of calcium in transport of secretory proteins from the endoplasmic reticulum. Cell. 61:1990;197-119.
15. Tatu U, Helenius A. Interactions between newly synthesized glycoproteins, calnexin and a network of resident chaperones in the endoplasmic reticulum. J Cell Biol. 136:1997;555-565.
16. Hammond C, Helenius A. Quality control in the secretory pathway, retention of a misfolded viral membrane glycoprotein involves cycling between the ER, intermediate compartment, and Golgi apparatus. J Cell Biol. 126:1994;41-52.
17. Harding HP, Zliang Y, Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature. 397:1999;271-274.
18. Silverman RH, Williams BR. Translational control perks up. Nature. 397:1999;208.
19. Shi Y, An J, Liang J, Hayes SE, Sandusky GE, Stramin LE, Yang NN. Characterization of a mutant pancreatic eIF-2alpha kinase, PEK, and co localization with somatostatin in islet delta cells. J Biol Chem. 274:1999;5723-5730.
20. Shi Y, Vattem KM, Sood R, An J, Liang J, Stramm L, Wek RC. Identification and characterization of pancreatic eukaryotic initiation factor 2 alpha-subunit kinase, PEK, involved in translational control. Mol Cell Biol. 18:1998;7499-7509.
21. Shamu CE, Walter P. Oligomerization and phosphorylation of the Ire1p kinase during intracellular signalling from the endoplasmic reticulum to the nucleus. EMBO J. 15:1996;3028-3039.
22. Shamu CE. Splicing: HACking into the unfolded-protein response. Curr Biol. 8:1998;121-123.
23. Sidrauski C, Walter P. The transmembrane kinase Irelp is a site-specific endonuclease that initiates mRNA splicing in the unfolded protein response. Cell. 90:1997;1031-1039.
24. Parodi AJ. Reglucosylation of glycoproteins and quality control of glycoprotein folding in the endoplasmic reticulum of yeast cells. Biochim Biophys Acta. 1426:1999;287-295.
25. Parodi AJ. The quality control of glycoprotein folding in the endoplasmic reticulum, a trip from trypanosomes to mammals. Braz J Med Biol Res. 31:1998;601-614.
26. Boston RS, Viitanen PV, Vierling E. Molecular chaperones and protein folding in plants. Plant Mol Biol. 32:1996;191-222.
27. Wada I, Rindress D, Cameron PH, Ou WJ, Doherty JJd, Louvard D, Bell AW, Dignard D, Thomas DY, Bergeron, JJ. SSR alpha and associated calnexin are major calcium binding proteins of the endoplasmic reticulum membrane. J Biol Chem. 266:1991;19599-19610.
28. Coppolino MG, Dedhar S. Calreticulin. Int J Biochem Cell Biol. 30:1998;553-558.
29. (2+)-binding protein (calmegin) specifically expressed during male meiotic germ cell development. J Biol Chem. 269:1994;7744-7749.
30. Ohsako S, Hayashi Y, Bunick D. Molecular cloning and sequencing of calnexin-t. An abundant male germ cell-specific calcium-binding protein of the endoplasmic reticulum. J Biol Chem. 269:1994;14140-14148.
31. Hammond C, Helenius A. Quality control in the secretory pathway. Curr Opin Cell Biol. 7:1995;523-529.
32. Wong HN, Ward MA, Bell AW, Chevet E, Bains S, Blackstock WP, Solari R, Thomas DY, Bergeron JJ. Conserved in vivo phosphorylation of calnexin at casein kinase II sites as well as a protein kinase C/proline-directed kinase site. J Biol Chem. 273:1998;17227-17235.
33. Chevet E, Wong HN, Gerber D, Cochet C, Fazel A, Cameron PH, Gushue JN, Thomas DY, Bergerou JJM. Phosphorylation by CK2 and MAPK enhances calnexin association with ribosomes. EMBO J. 18:1999;3655-3666.
34. Kopito RR. ER quality control. The cytoplasmic connection. Cell 8. 8:1997;427-430.
35. Liu Y, Choudhury P, Cabral CM, Sifers RN. Intracellular disposal of incompletely folded human alpha1-antitrypsin involves release from calnexin and post-translational trimming of asparagine-linked oligosaccharides. J Biol Chem. 272:1997;7946-7951.
36. Liu Y, Choudhury P, Cabral CM, Sifers RN. Oligosaccharide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome. J Biol Chem. 274:1999;5861-5867.
37. Kaufman RJ, Pipe SW, Tagliavacca L, Swaroop M, Moussalli M. Biosynthesis, assembly and secretion of coagulation factor VIII. Blood Coagul Fibrinolysis 8 Suppl. 2:1997.
38. Pipe SW, Morris JA, Shah J, Kaufman RJ. Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin. J Biol Chem. 273:1998;8537-8544.
39. Majoul I, Sohn K, Wieland FT, Pepperkok R, Pizza M, Hillemann J, Soling HD. KDEL receptor (Erd2p)-mediated retrograde transport of the cholera toxin A subunit from the Golgi involves COPI, p23, and the COOH terminus of Erd2p. J Cell Biol. 143:1998;601-612.
40. Rapak A, Falnes PO, Olsnes S. Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol. Proc Natl Acad Sci USA. 94:1997;3783-3788.
41. Schue V, Green GA, Girardot R, Monteil H. Hyperphosphorylation of calnexin, a chaperone protein, induced by Clostridium difficile cytotoxin. Biochem Biophys Res Commun. 203:1994;22-28.
42. Mirazimi A, Nilsson M, Svensson L. The molecular chaperone calnexin interacts with the NSP4 enterotoxin of rotavirus in vivo and in vitro. J Virol. 72:1998;8705-8709.
43. Theuer CP, Buchner J, FitzGerald D, Pastan I. The N-terminal region of the 37-kDa translocated fragment of Pseudomonas exotoxin A aborts translocation by promoting its own export after microsomal membrane insertion. Proc Natl Acad Sci USA. 90:1993;7774-7778.
44. Simpson JC, Dascher C, Roberts LM, Lord JM, Balch WE. Ricin cytotoxicity is sensitive to recycling between the endoplasmic reticulum and the Golgi complex. J Biol Chem. 270:1995;20078-20083.
45. Wales R, Roberts LM, Lord JM. Addition of an endoplasmic reticulum retrieval sequence to ricin A chain significantly increases its cytotoxicity to mammalian cells. J Biol Chem. 268:1993;23986-23990.
46. Sandvig K, Garred O, Prydz K, Kozlov JV, Hansen SH, van Deurs B. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature. 358:1992;510-512.
47. Philpott DJ, Ackerley CA, Kiliaan AJ, Karmali MA, Perdue MH, Sherman PM. Translocation of verotoxin-1 across T84 monolayers: mechanism of bacterial toxin penetration of epithelium. Am J Physiol. 273:1997.
48. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan CR, Smith AE. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell. 63:1990;827-834.
49. Yang Y, Janich S, Cohn JA, Wilson JM. The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi non-lysosomal compartment. Proc Natl Acad Sci USA. 90:1993;9480-9484.
50. Meacham GC, Lu Z, King S, Sorscher E, Tousson A, Cyr DM. The Hdj-2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis. EMBO J. 18:1999;1492-1505.
51. Ward CL, Omura S, Kopito RR. Degradation of CFTR by the ubiquitin proteasome pathway. Cell. 83:1995;121-127.
52. Pind S, Riordan JR, Williams DB. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J Biol Chem. 269:1994;12784-12788.
53. Johnston JA, Ward CL, Kopito RR. Aggresomes: a cellular response to misfolded proteins. J Cell Biol. 143:1998;1883-1898.
54. Loo MA, Jensen TJ, Cui L, Hou Y, Chang XB, Riordan JR. Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome. EMBO J. 17:1998;6879-6887.
55. Le A, Steiner JL, Ferrell GA, Shaker JC, Sifers RN. Association b etween calnexin and a secretion-incompetent variant of human alpha 1-antitrypsin. J Biol Chem. 269:1994;7514-7519.
56. Xiong X, Bragin A, Widdicombe JH, Cohn J, Skach WR. Structural cues involved in endoplasmic reticulum degradation of G85E and G91R mutant cystic fibrosis transmembrane conductance regulator. J Clin Invest. 100:1997;1079-1088.
57. DeLeo FR, Goedken M, McCormick SJ, Nauseef WM. A novel form of hereditary myeloperoxidase deficiency linked to endoplasmic reticulum/proteasome degradation. J Clin Invest. 101:1998;2900-2909.
58. Nauseef WM, McCormick SJ, Goedken M. Coordinated participation of calreticulin and calnexin in the biosynthesis of myeloperoxidase. J Biol Chem. 273:1998;7107-7111.
59. Voorberg J, de Laaf RT, Koster PM, van Mourik JA. Intracellular retention of a factor VIII protein with an Arg2307->Gln mutation as a cause of haemophilia A. Biochem J. 318:1996;931-937.
60. Kim PS, Arvan P. Calnexin and BiP act as sequential molecular chaperones during thyroglobulin folding in the endoplasmic reticulum. J Cell Biol. 128:1995;29-38.